

share
Garenoxacin CAS NO 194804-75-6
Unit Price:
CAS No.:194804-75-6
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Garenoxacin CAS NO 194804-75-6 is a synthetic broad-spectrum fluoroquinolone antibiotic agent. This compound is significant for its potent activity against a wide range of Gram-positive and Gram-negative bacteria, including drug-resistant strains. It is primarily utilized by pharmaceutical research and development organizations for the synthesis of novel antibacterial drugs and as a critical reference standard in analytical testing.
Application
- Pharmaceutical Intermediate: Serves as a key building block in the synthesis of advanced antibacterial agents and prodrugs.
- Reference Standard: Used in analytical laboratories for method development, validation, and quality control testing of pharmaceutical products.
- Biomedical Research: Employed in microbiological and pharmacological studies to investigate mechanisms of action and resistance against bacterial pathogens.
- Antibacterial Agent Development: Acts as a lead compound for the research and development of new-generation fluoroquinolone antibiotics.
Basic Information
| Product Name | Garenoxacin |
| CAS No. | 194804-75-6 |
| Molecular Formula | C₁₇H₁₉FN₄O₄ |
| Molecular Weight | 362.36 g/mol |
| Synonyms | BMS-284756; T-3811; (R)-7-(3-Amino-2,3-dihydro-1H-isoindol-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AM-1155; Garenoxacin mesylate; OPC-17116; DU-6859a |
| EINECS | Contact for details |
Quality Control
Our Garenoxacin is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, residual solvent analysis, and identity confirmation via spectroscopic methods. A Certificate of Analysis (COA) detailing all test results is provided to ensure traceability and compliance with your research or production standards.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment to prevent moisture absorption.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to reference spectrum |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | ≥ 98.0% |
| Related Substances (HPLC) | Total impurities ≤ 2.0% Any single impurity ≤ 0.5% |
| Water Content (KF) | ≤ 1.0% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Gemifioxacin Mesylate CAS NO 210353-53-0


Ciprofloxacin CAS NO 85721-33-1


Sodium Oxolinate CAS NO 1391-41-9


Oxolinic Acid CAS NO 14698-29-4


Nalidixic Acid Sodium Salt Hydrate 97 CAS NO 15769-77-4


Clantifen CAS NO 16562-98-4


Moxicoumone CAS NO 17692-56-7


Quinespar CAS NO 18921-66-9


Piromidic Acid CAS NO 19562-30-2


6,8-Difluoro-1,4-Dihydro-1-(Methylamino)-7-(4-Methyl-1-Piperazinyl)-4-Oxo-3-Quinolinecarboxylic Acid Sulfate CAS NO 100276-37-7


Tosufloxacin Tosilate CAS NO 100490-36-6


Tosuflo CAS NO 100490-94-6


Norfloxacin Succinil CAS NO 100587-52-8


Levofloxacin CAS NO 100986-85-4


D-Ofloxacin CAS NO 100986-86-5


Rufloxacin CAS NO 101363-10-4


3-Quinolinecarboxylic Acid, 8-Chloro-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-7-(3-Methyl-1-Piperazinyl)-4-Oxo- CAS NO 101987-76-2


Oxociprofloxacin CAS NO 103237-52-1


8-Demethoxy-8-Fluoro Gatifloxacin CAS NO 103460-89-5


6-Fluoro-7-(1-Piperazinyl)-1-(2'-Phenyl-1'-Cyclopropyl)-1,4-Dihydro-4-Oxoquinoline-3-Carboxylic Acid CAS NO 103531-48-2
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






